Nine-year follow-up of children with atopic dermatitis by general practitioners

Laurent Misery1, Xavier Ansolabehere, Nathalie Grandfils

  • 1Department of Dermatology, University Hospital of Brest, Brest, France.

Dermatology (Basel, Switzerland)
|March 26, 2014
PubMed

Insights

Infants with atopic dermatitis (AD) experience more comorbidities, particularly respiratory and ophthalmic conditions. These children also incur higher medical costs for treatments, though this difference decreases with age.

Area of Science:

  • Dermatology
  • Pediatrics
  • Public Health

Background:

  • Atopic dermatitis (AD) is a common chronic inflammatory skin condition in infants.
  • The full extent of comorbidities and treatment costs associated with childhood AD in primary care is not well-established.

Purpose of the Study:

  • To investigate the frequency of associated comorbidities in infants diagnosed with AD.
  • To quantify the treatment costs for patients with AD compared to a control group in a primary care setting.

Main Methods:

  • Retrospective cohort study utilizing a longitudinal electronic medical records database in France.
  • Matched cohort of 1,163 infants with AD (diagnosed in the first year of life) and 1,163 controls, followed for 9 years.
  • Detailed analysis of associated diseases, drug prescriptions, and medical costs.

Main Results:

  • Infants with AD exhibited a higher prevalence of comorbidities, notably affecting the respiratory and ophthalmic systems.
  • Patients with AD incurred greater healthcare expenditures, including general practitioner consultations and prescribed medications.
  • The disparity in medical costs between AD patients and controls diminished as the children aged.

Conclusions:

  • Childhood atopic dermatitis is linked to increased comorbidity burden and higher healthcare costs in primary care.
  • Early diagnosis and management of AD may be crucial for mitigating long-term health impacts and economic consequences.